Misplaced Pages

Occupational asthma is new onset asthma or the recurrence of previously quiescent asthma directly caused by exposure to an agent at workplace. It is an occupational lung disease and a type of work-related asthma. Agents that can induce occupational asthma can be grouped into sensitizers and irritants.

Sensitizer-induced occupational asthma is an immunologic form of asthma which occurs due to inhalation of specific substances (i.e., high-molecular-weight proteins from plants and animal origins, or low-molecular-weight agents that include chemicals, metals and wood dusts) and occurs after a latency period of several weeks to years.

Irritant-induced (occupational) asthma is a non-immunologic form of asthma that results from a single or multiple high dose exposure to irritant products. It is usually develops early after exposure; however, it can also develop insidiously over a few months after a massive exposure to a complex mixture of alkaline dust and combustion products, as shown in the World Trade Center disaster. Unlike those with sensitizer-induced occupational asthma, subjects with irritant-induced occupational asthma do not develop work-related asthma symptoms after re-exposure to low concentrations of the irritant that initiated the symptoms. Reactive airways dysfunction syndrome (RADS) is a severe form of irritant induced asthma where respiratory symptoms usually develop in the minutes or hours after a single accidental inhalation of a high concentration of irritant gas, aerosol, vapor, or smoke.

Another type of work-related asthma is work-exacerbated asthma (WEA) which is asthma worsened by workplace conditions but not caused by it. WEA is present in about a fifth of patients with asthma and a wide variety of conditions at work, including irritant chemicals, dusts, second-hand smoke, common allergens that may be present at work, as well as other "exposures" such as emotional stress, worksite temperature, and physical exertion can exacerbate asthma symptoms in these patients. Both occupational asthma and work-exacerbated asthma can be present in an individual.

A number of diseases have symptoms that mimic occupational asthma, such as asthma due to nonoccupational causes, chronic obstructive pulmonary disease (COPD), irritable larynx syndrome, hyperventilation syndrome, hypersensitivity pneumonitis, and bronchiolitis obliterans.

Signs and symptoms

Like other types of asthma, it is characterized by airway inflammation, reversible airways obstruction, and bronchospasm, but it is caused by something in the workplace environment. Symptoms include shortness of breath, tightness of the chest, coughing, sputum production and wheezing. Some patients may also develop upper airway symptoms such as itchy eyes, tearing, sneezing, nasal congestion and rhinorrhea.

Symptoms may develop over many years as in sensitizer-induced asthma or may occur after a single exposure to a high-concentration agent as in case of RADS.

Risk factors

At present, over 400 workplace substances have been identified as having asthmagenic or allergenic properties. Agents such as flour, diisocyanates, latex, persulfate salts, aldehydes, animals, wood dusts, metals, enzymes usually account for the majority cases; however, the distribution of causal agents may vary widely across geographic areas, depending on the pattern of industrial activities. For example, in France the industries most affected are bakeries and cake-shops, automobile industry and hairdressers, whereas in Canada the principal cause is wood dust, followed by isocyanates. Furthermore, the most common cause of occupational asthma in the workplace are isocyanates. Isocyanates are used in the production of motor vehicles and in the application of orthopaedic polyurethane and fibreglass casts.

The occupations most at risk are: adhesive handlers (e.g. acrylate), animal handlers and veterinarians (animal proteins), bakers and millers (cereal grains), carpet makers (gums), electronics workers (soldering resin), forest workers, carpenters and cabinetmakers (wood dust), hairdressers (e.g. persulfate), health care workers (latex and chemicals such as glutaraldehyde), janitors and cleaning staff (e.g. chloramine-T), pharmaceutical workers (drugs, enzymes), cannabis cultivation and processing technicians (e.g. organic particulate matter and dust from plants, mold, endotoxins), seafood processors, shellac handlers (e.g. amines), solderers and refiners (metals), spray painters, insulation installers, plastics and foam industry workers (e.g. diisocyanates), textile workers (dyes) and users of plastics and epoxy resins (e.g. anhydrides).

The following tables show occupations that are known to be at risk for occupational asthma. The main reference is the Canadian Centre for Occupational Health and Safety.

Diagnosis

To diagnose occupational asthma it is necessary to confirm the symptoms of asthma and establish the causal connection with the work environment. Various diagnostic tests can be used to aid in diagnoses of work-related asthma.

A spirometer is a device used to measure timed expired and inspired volumes, and can be used to help diagnose asthma.

A peak flow meter is a hand-held device which measures how fast a person can exhale – peak expiratory flow rate (PEFR) – and is a reliable test for occupational asthma. Serial PEFR can be measured to see if there is a difference in ability to exhale at work compared to that in a controlled environment.

A non-specific bronchial hyperreactivity test can be used to support the diagnose occupational asthma. It involves measuring the forced expiratory volume in 1 second (FEV-1) of the patient before and after exposure to methacholine or mannitol. Presence of airway responsiveness, i.e. significant drop in FEV-1, can be seen in patients with occupational asthma.

Specific inhalation challenges test consist of exposing the subjects to the suspected occupational agent in the laboratory and/or at the workplace and assessing for asthma symptoms as well as a reduction in FEV₁.

Other tests such as the skin prick test, serum immunologic testing and measurement of sputum eosinophils can also be useful in establishing the diagnosis of occupational asthma.

Prevention

Several forms of preventive measures have been suggested to prevent development of occupational asthma and also detect risk or disease early to allow intervention and improve outcomes. These include: comprehensive programs, education and training, medical examinations, use of medications, reduction of exposures and elimination of exposures. A review on the effectiveness of prevention measurements indicated that removal or reduction of exposure may improve asthma symptoms when compared to uninterrupted exposure. Removal from exposure may improve lung function when compared to continued exposure. Removal from exposure may improve symptoms and lung function more than reduction of exposure among patients exposed to low molecular weight agents, such as isocyanates, diisocyanates, plicatic acid, metals and anhydrides. Two studies reported an increase of job loss associated with removal from exposure. Four studies reported a decrease in income of 20% to 50% after removal from exposure. The authors suggested that the benefit of a better improvement in air quality be weighed against the potential for a higher risk of job loss.

Asthma symptoms and airway hyperresponsiveness can persist for several years after removal from the offending environment. Thus, early restriction from exposure to the trigger is advisable. Completely stopping exposure is more effective treatment than reducing exposure, but not always feasible.

Management

Medication

Medications used for occupational asthma are similar to those used for other types of asthma such as short-acting beta-agonists like salbutamol or terbutaline, long-acting beta-agonists like salmeterol and formoterol and inhaled corticosteroids. Immunotherapy can also be used in some cases of sensitizer-induced occupational asthma.

Epidemiology

Occupational asthma is one of the most common occupational lung disease. Approximately 17% of all adult-onset asthma cases are related to occupational exposures. About one fourth of adults with asthma have work-exacerbated asthma. Patients with work-related asthma are more likely to experience asthma attacks, emergency room visits, and worsening of their asthma symptoms compared with other adult asthma patients.

Society and culture

Compensation

When a person is diagnosed with occupational asthma, it can result in serious socio-economic consequences not only for the workers but also for the employer and the healthcare system because the worker must change positions. The probability of being re-employed is lower for those with occupational asthma compared to those with normal asthma. The employer not only pays compensation to the employee, but will also have to spend a considerable amount of time and energy and funds for hiring and training new personnel. In the United States, it was estimated that the direct cost of occupational asthma in 1996 was $1.2 billion and the indirect cost $0.4 billion, for a total cost of $1.6 billion. In most cases, the employer could have saved more money by adhering to safety standards rather than causing employees to become injured.

However, this can entail severe socio-economic consequences for the worker as well as the employer due to loss of job, unemployment, compensation issues, medical expenditures, and hiring and re-training of new personnel.

See also

• Chronic obstructive pulmonary disease (COPD)
• Specific inhalation challenge
• Occupational safety and health
• National Institute of Occupational Safety and Health (NIOSH)
• Labor rights

References

1. ^ Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. (September 2008). "Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement". Chest. 134 (3 Suppl): 1S–41S. doi:10.1378/chest.08-0201. PMID 18779187.
2. ^ Lemiere C, Vandenplas O (2016). "Asthma in the Workplace". In Broaddus VC, Mason RJ, Ernst JD, King TE, Lazarus SC, Murray JF, Nadel JA, Slutsky AS, Gotway MB (eds.). Murray & Nadel's Textbook of Respiratory Medicine (6th ed.). Philadelphia, Pa.: Elsevier Saunders. pp. 1295–1306. ISBN 978-1-4557-3383-5.
3. ^ Tarlo SM, Lemiere C (February 2014). "Occupational asthma". The New England Journal of Medicine. 370 (7): 640–649. doi:10.1056/NEJMra1301758. PMID 24521110.
4. ^ Henneberger PK, Redlich CA, Callahan DB, Harber P, Lemière C, Martin J, et al. (August 2011). "An official american thoracic society statement: work-exacerbated asthma". American Journal of Respiratory and Critical Care Medicine. 184 (3): 368–378. doi:10.1164/rccm.812011ST. PMID 21804122.
5. "Asthma & Allergies". National Institute for Occupational Safety and Health (NIOSH). April 3, 2012.
6. "Table of agents and substances which can cause asthma". AsmaPro. Archived from the original on 24 October 2006.
7. Baur X, Bakehe P (May 2014). "Allergens causing occupational asthma: an evidence-based evaluation of the literature". International Archives of Occupational and Environmental Health. 87 (4): 339–363. Bibcode:2014IAOEH..87..339B. doi:10.1007/s00420-013-0866-9. PMID 23595938. S2CID 38640302.
8. ^ de Groene GJ, Pal TM, Beach J, Tarlo SM, Spreeuwers D, Frings-Dresen MH, et al. (May 2011). "Workplace interventions for treatment of occupational asthma". The Cochrane Database of Systematic Reviews (5): CD006308. doi:10.1002/14651858.CD006308.pub3. PMID 21563151.
9. Ameille J, Pauli G, Calastreng-Crinquand A, Vervloët D, Iwatsubo Y, Popin E, et al. (February 2003). "Reported incidence of occupational asthma in France, 1996-99: the ONAP programme". Occupational and Environmental Medicine. 60 (2): 136–141. doi:10.1136/oem.60.2.136. PMC 1740458. PMID 12554842.
10. ^ Chan-Yeung M, Malo JL (July 1995). "Occupational asthma". The New England Journal of Medicine. 333 (2): 107–112. doi:10.1056/NEJM199507133330207. PMID 7777015.
11. Weaver VM, Hua JT, Fitzsimmons KM, Laing JR, Farah W, Hart A, et al. (November 2023). "Fatal Occupational Asthma in Cannabis Production - Massachusetts, 2022". MMWR. Morbidity and Mortality Weekly Report. 72 (46): 1257–1261. doi:10.15585/mmwr.mm7246a2. PMC 10684356. PMID 37971937.
12. "Occupational asthma". Mayo Clinic. 23 May 2009.
13. ^ "OSH Answers Asthma, Work-related". Canadian Centre for Occupational Health and Safety. December 16, 2013.
14. ^ Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, et al. (March 2012). "Guidelines for the management of work-related asthma". The European Respiratory Journal. 39 (3): 529–545. doi:10.1183/09031936.00096111. PMID 22379148.
15. ^ Hegmann KT, Biggs JJ, Hughes MA, Jolly AT, Klees JE (eds.). "Occupational/Work-Related Asthma Medical Treatment Guideline" (PDF). American College of Occupational and Environmental Medicine.
16. Moscato G, Godnic-Cvar J, Maestrelli P, Malo JL, Burge PS, Coifman R (September 1995). "Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of the European Academy of Allergology and Clinical Immunology. American Academy of Allergy and Clinical Immunology. European Respiratory Society. American College of Allergy, Asthma and Immunology". The European Respiratory Journal. 8 (9): 1605–1610. doi:10.1183/09031936.95.08091605. PMID 8575590.
17. Vandenplas O, Suojalehto H, Aasen TB, Baur X, Burge PS, de Blay F, et al. (June 2014). "Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement". The European Respiratory Journal. 43 (6): 1573–1587. doi:10.1183/09031936.00180313. PMID 24603815.
18. Tarlo SM, Liss GM (July 2010). "Prevention of occupational asthma". Current Allergy and Asthma Reports. 10 (4): 278–286. doi:10.1007/s11882-010-0118-y. PMID 20424999. S2CID 20166471.
19. "Prevention of Work-related Asthma". National Institute for Occupational Safety and Health (NIOSH). 2018-11-23.
20. ^ Henneberger PK, Patel JR, de Groene GJ, Beach J, Tarlo SM, Pal TM, et al. (Cochrane Work Group) (October 2019). "Workplace interventions for treatment of occupational asthma". The Cochrane Database of Systematic Reviews. 10 (10): CD006308. doi:10.1002/14651858.CD006308.pub4. PMC 6781842. PMID 31593318.
21. ^ "Work-related asthma". National Institute for Occupational Safety and Health (NIOSH). 2019-01-03.
22. ^ Cowl CT (March 2011). "Occupational asthma: review of assessment, treatment, and compensation". Chest. 139 (3): 674–681. doi:10.1378/chest.10-0079. PMID 21362654.
23. "Occuptational Asthma". MedlinePlus Medical Encyclopedia.
24. Dewitte JD, Chan-Yeung M, Malo JL (May 1994). "Medicolegal and compensation aspects of occupational asthma". The European Respiratory Journal. 7 (5): 969–980. doi:10.1183/09031936.94.07050969. PMID 8050556. S2CID 41120422.
25. Leigh JP, Romano PS, Schenker MB, Kreiss K (January 2002). "Costs of occupational COPD and asthma". Chest. 121 (1): 264–272. CiteSeerX 10.1.1.455.4942. doi:10.1378/chest.121.1.264. PMID 11796461.

External links

• Epidemiology and Pathophysiology of Work-related Asthma, National Institute for Occupational Safety and Health.
• Occupational asthma and work aggravated asthma (UK) Archived 2015-06-24 at the Wayback Machine
• Work-related Asthma, National Institute for Occupational Safety and Health.

• Asthma
• Occupational diseases